GB2233666A - Microbacterium 851R, and a process for producing 851 nutrient solution - Google Patents
Microbacterium 851R, and a process for producing 851 nutrient solution Download PDFInfo
- Publication number
- GB2233666A GB2233666A GB9010885A GB9010885A GB2233666A GB 2233666 A GB2233666 A GB 2233666A GB 9010885 A GB9010885 A GB 9010885A GB 9010885 A GB9010885 A GB 9010885A GB 2233666 A GB2233666 A GB 2233666A
- Authority
- GB
- United Kingdom
- Prior art keywords
- strain
- ppm
- medium
- mice
- nutrient solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A mutant of Microbacterium named 851R, the main characteristics of which are as follows: a Gram- positive bacterium, motionless, with nitrate reduction ability, able to produce H2S, alive in milk heated to 63 DEG C for 30 minutes or to 72 DEG C for 15 minutes. The thallus is of red or orange red colour is described. However, the colour of the thallus is turned to pink at about 38 DEG C and to colourless to 40 DEG C. In particular, the DNA of the strain contains R fragment which is detectable with a special R fragment DNA probe. A process for producing single cell protein nutrient solution comprises cultivating Microbacterium strain 851/R in a soybean medium or starch medium. The medium comprises (in addition to soybeam or starch) yeast, calcium carbonate, sodium chloride, potassium hydrogen phosphate, magnesium sulphate and traces of sodium malybdate, sodium selenite, zinc sulphate and cobalt ( PI ) chloride.
Description
A mutant of Microbacterium ,A strain 851R, and a process
for producing 851 nutrient solution by aPPlication of the strain
The technical fleld of the Invention
This Invention relates to a mutant of flicrobacterluii , particularly relates to a strain named 851R and an industrial fermentation process making use of the strain as a producing strain to produce single cell protein nutrient solution and a process for giving a nutrient solution.
The background of the invention
Nowadays many ways have been tried to select ntcroorganisms which can be adopted in industrial fermentation to produce single cell protein easier to be assiminated by human body. The inventor of the present invention has made a method known to the public , which is a method to produce Se enriched single cell protein, Vitamin E nutrient solution and bacterta manure with an ammonia resistance azotobacter. This method offers a cultivated azotobacter which possesses ammonia resistance and nitrogen flxing ability to make use of atmospheric nitrogen to produce single cell protein solution enriched with Zn, Se and vitamins by conventional industrial fermentation method.
The objective and summary of the invention
The objective of this invention makes use of the strain 851R as a producing strain and is to provide conventional industrial fermentation method as a method to produce 851 nutrient solution by means of cultivating the strain 851R and designing proper media for the growth of the strain 851R ,in which soybean acts as a main material.
Soybean is a kind of protein-rich food. Because soybean contains proteinase inhibitors , soybean protein is difficult to be totally assiminated by human body. However , after being assiminated by the bacterium of the strain 851R.
soybean protein is converted to single cell protein nutrient solution which is not only a protein source easily to be assiminated by human body but also a kind of nutrient solution with the following effects : naking central nurvous system healthy , organism immunologic enhancement , endocrine function regulation, antisenility, some kinds of cancer cell growth Inhibition.
The microorganism related to this invention is a mutant of Microbacterium, named 851R. The main characteristics of this strain are as follows : a Gram positive bacterium . motionless , with nitrate reduction ability , able to produce iS , alive in milk heated at 63 C for 30 minutes or at 72 C for 15 minutes. The thallus is of red or orange red colour. However , the colour of the thallus is turned to pink at about 38 C and to colourless at 40 C. in particular , the DNA of this strain contains R fragment which is detectable with a special R fragment DNA probe.
The Invention also relates to an industrial method which makes use of bacteria to produce single cell protein nutrient solution. In this method, the
Microbacterium strain 851R cultivated in this invention acts as the producing strain4 soybean medium or starch medium acts as the producing media.
Detailed descriptlon of the invention
The microorganism related to this invention is a mutant of Microbacterium named flicrobacterium 851R. The main characteristics are as follows : a Gran- positive rod , motionless , with glycerolraffinose assimination ability, nitrate reduction ability , H25-producing ability. alive in milk heated at 63
C for 30 minutes or at 72 C for 15 minutes. The thallus is of red or orange red colour , the colour of the thallus is turned to pale at 38 C and to colourless at 40 C. In particular , The DNA of the strain contains R fragment which is detectable with a special R fragment DNA probe.
A strain 851R , a mutant of Microbacterium , has the essential characteristics of the sample on deposit with American Type Culture Collection.12301 Parklawn Drive, Rockville, Maryland 20852 USA , and assigned A.T.C.C. No.53981.
The strain of 851R possesses distinctive characteristics to be distinguished from other strains in the Renus of Microbacterlum. The application of the strain 851R as a producing strain and the application of the nitrogen sourcecontaining media designed and used in this invention can produce a single cell protein solution enriched with peptides , a variety of trace elements and vitamins (listed in an analytical report of the culture solution).More than 20 amino acids are contained in the culture solution. 100 ml of this culture solution contain : 593-4172 mR of amino acids, 0.3-1.0 mg of vitamin E, 8,1- 0.3 mg of vitamin B , 0.5-1.0 mg of vitamin PP, 1.0-5.0 ppm of Se, 10-20 ppm of Zn , 5.0-18 ppm of Mo , 5.0-10 ppm of Co, 5-15 ppm of Mn, and 3.0-10 ppm of
Cu.
The media formulated and used in the invention by weight are as follows: 1. Soybean medium:
Soybean powder 5 - 10 % or soybean milk (calculated by the weight of soybean) 5 - 20 % or various been cakes, sunflower seed cake 5 - 10 %
Yeast extract or yeast powder 0,02 - 0.5 %
CaCO3 0.05 - 0.5 %
K2HPO4 0.02 - 0.2 %
MRSO4 0.01 - 0,08 %
NaCI 0,01 - 0,08 %
Na2MoO4 5.0 - 50 ppm
Na2SeO3 1.5 - 10 ppm
ZnSO4 2.5 - 50 ppm
CoCl2 2.5 - 20 ppm 2.Starch medium:
Fresh materials containing starch 10 - 20 %
(Sweet potato, potato etc.) or dry materials containing starch 1
(Corn powder etc.)
Yeast extract 0.04 - 0.08 % K2HPO4 0.05 - 0.1 %
MgSO4 0.02 - 0.04 % CaCO3 0.05 - 0.5 % NaCl 0.02 - 0.04 %
NaMoO4 10 - 20 ppm
Na2SeO3 1.5 - 20 ppm ZnSO4 5 - 20 ppm CoCl2 5 - 20 ppm
Proper amounts of other trace elements necessary to human body may be added to the media mentioned above. The amounts of elements are in the range of 1.5 - 100 ppm.
A process for producing a nutrient solution by application of the strain 851R comprises the following steps : aeration culture is adopted in conventional tank fermenter installed with stirrer and gas transfer and when required, the fermenter can provide culture agitating to make cultures homogenized and can also provide culture aeration with filtered aseptic air to meet the oxygen need of bacterium and other microorganisms during culture period. The 851R strain being acting as a producing strain is propagated in the media formulated in this invention. After the three-step culture (the first , second and third seed culture ) , the thallus is inoculated into a preautoclaved producing medium and incubated for 36-64 hrs.During the culture period, aseptic air is passed through the medium, the aeration rate : 1:0.5-1.0 vvm, stirring speed : 180-260 rpm, culture temperature : 28oC-40 C. After the incubation is finished, the culture broth is autoclaved and harvested. Then the culture solution is directly packed to give products, also various series of products can be obtained by different processing methods to fulfill a variety of needs. Cola-tye drinks may be prepared from the culture solution after precipitation and centrifugation at 15000 rpm, pressure (-0.2) -- (- 0.4) kg/cm2. After concentration, the culture solution becomes concentrated nutrients. After being oven dried or spray dried, the culture solution is transformed into powder form and can be further processed to give capsules or tablets.For spray drying, the temperature at the entrance is 80"C-300"C, and 60aC-120QC at the exit. The culture solution can be added to wheat flour to bake bread and cake or other foods to replace water and eggs. The culture solution can also be used in the production of cosmetics.
The 851 nutrient solution possesses effects of anti-aging, improving constitutions, keeping liver and stomach in good condition, inhibiting cancer cell growth, stimulating and improving hemogenesis of organisms, restoration of gastric mucosa injury, a therapeutic action on acute bleeding of gastric mucosa, a therapeutic action on liver injury and, the effect of restoration of puerperal constitution. The following experiments give the details.
Experiment 1 Anti-lipd peroxidative effect
Male Kunming mice, weighing 17.8 + 1.75 g. were used and divided into several groups according to body weight. Each group consisted on 10 mice. The tested mice were fed with 851 nutrient solution (abbreviated to 851 NS) instead of tap water for consecutive 13 days and fasted at 14th day. Then half of these tested mice were fed with tap water instead of 851 NS. Another half of the tested mice were continuously allowed to drink 851 nutrient, solution and administered with CC1, intraperetoneally at 4 O'clock in the afternoon.
Mice of the control group were supplied with the same diet as the tested group , except tap water instead of 851 NS and administered with paraffin oil (dissolvent of CCl,) intraperetoneally at 14th day.
nice of CCl. control group were supplied with the same diet and drunk tap water. The animals were fasted and administered with CCl, (1.87mmol/kg) intraperetoneally at afternoon.
At 15th day , the animals were decapitated and the liver sample were prepared.
MDA of the liver was detected according to the method of Hiroshi Ohakawa tHiroshi Ohakava et al. Anal. Biochem. 95 :351-358 , 1979 ), 1 ,1 ,3 ,3 ,tetramethoxy propane ( product of Japan TCI , E.P. grade ) was used as a standard sample for the detection of lipid peroxide , spectrophotometer was used to detect the absorbance of MDA. MDA content is indicated as nmol/g liver. The data were analysized statistically.The results were as follows:
group number of MDA nmol/g liver p value
mouse (H+SD ) compared to compared to
control group CCl4 group control 10 119.5+27.2 - - CCl 10 1698.9+28.76 < 0.001 CCl +851 8 139.3+191.8 < 0.001
The results indicated that 851 nutrient substantially solution possessed potent anti -lipid peroxidative activity in certain condition which might be useful for anti-aging.
Experiment 2 Swimming Test
Male Kunmming mice, weighing 15-24g , were used and divided into several groups. The mice were fed with water4 ginseng, Nestle milk powder and 851 NS, respectively.
Mice of 851 NS group were fed with 851 NS (5-6ml/day) instead of tap water for 4 days.
Mice of control group were fed with tap water for 4 days.
Mice of Nestle milk powder group were fed with 0.01% Nestle milk powder instead of tap water for A days.
Crude ginseng was minced into slices and immense in bolting water for about 3 hrs and then boiled with gental heat for 15 minutes twlcely and prepared in 8.881 % concentration to feed mice instead of tap water for 4 days.
Swimming test was performed according to the method of Wang Yun-muo (Journal of Shanghai Medicine 2: 46-48, 1985). The results were shown as follows:
Group Water Crude ginseng Nestle milk powder 851NS
Number of 7 9 10 19
mouse
Swimming time
(second) 104.3+18.9 172+6.2 186.5+88.1 199.8+9e.5 p value compared to - < 0.025 < 0.05 < 0,025 water group
The results indicated that 851 nutrient solution significantly increased swimming time of mice and improved mices physique.
Experiment 3 Inhibitory effect on gastric cancer cell (FGC)
After discarding the used culture solution, gastric cancer cell (FGC), in good reproducing state, were digested with .2 % EDTA and washed with 1640 medium containing 15% bovine serium. Live cells were counted with tryphan blue and cultured in a total volume of 1ml (1x105/ml) at 37 C for 24 hrs. Then the cells were washed and cultured in the same medium contain 851NS (0.2 ml/ml).
Cells of the control group were cultured in a volum of 1 ml medium (10 ml of 1640 medium containing 15% bovine serlum and 2ml Of 851 NS ) at 37 C for 24 hrs. The wells of each group were duplicated.Then the used medium was discarded. 0.9ml 0.02% EDTA and 0.1ml tryphan blue were added and live cells were counted.
n1 n2
inhibiting rate = ~~~~~~~~~~~~~~~~~~ X 100% n1 n1 and n2 were the number of live cells in control group and tested group respectively,
The results indicated that the mean inhibition rate of 851 NS on the gastric cancer cells was 30%.
Experiment 4 Effect on Euplotes crassus Cell Division
Euplotes crassus is a singular cell organism, which lives in seawater. The age of the cell is accouted by its asexual reproduction generation4 ranged between 1000-1500.
Aging of Euplotes crassus cell is associated with some metabolic changes.
Among these changes, the decrease of speed of cell division is one of the most significant characteristic of cell aginR, The division speed of Euplotes crassus cell was significantly increasd when the cells cultured in the seawater containing 10% 851 NS. The cell division speed (generation/ day) of 5 days during the culture period was listed as follows: 851 NS. Speed of cell division
day 1 day 2 day 3 day 4 day 5 0 2.58 2.63 2.58 2.60 2.40
10% 4.00 3.70 2.86 4.13 4.00
The above table showed that the division speed of Euplotes crassus cell was increased 1.11-1.67 times when the seawater culture medium containing 10% 851
NS. Cell metabolism was improved when 851 NS was phagocytized into cells.
The division speed of the aged Euplotes crassus cell (aged 200 generation) was increased 1.4 times (from 8.33 to 0.79 generatton/day ) when culture medium containing 10% 851 nutrient solution.
The results indicated that 851 nutrient solution could improve the metabolism of the aged cells.
Experiment 5 Effect of 851NS on body weight , homoglobin and white cell clasification of newly born mice 1. Materials:
Kunming mice were supplied by the animal center of Fulian Medical College. The batch number of 851 nutrient solution was 86.
2. Methods:
Twelve Kunming pregnant mice were fed with normal diet and tap water separately After parturation , the 12 mice were divided.into control and 851
NS group in random. The newborn mice were at a litter weighed when suckled.
The female and newborn mice of control and 851 NS group were fed with normal diet or the diet containing 851 NS , respectively , during the period of suckling and 15 days after weaning. Then the newborn mice were weighed at a litter. The blood sample was taken from the eye ball of the newborn mice. The increase of the body weight4 and clasification of white cells of newborn mice were shown as follows:
Results and discussion 1. Results: 1.1 Table 1 showed body weight changes of newborn mice.
Table 1 Effect of 851NS on body weight increase of
the newborn mice
brood number newborn mice body weight p value*
number increase of
each newborn
mouse (g. x+ SD) control 4 34 14.20+0,75 851 4 34 14.36+1.29 < 8.85 * Compared with control group 1.2 Table 2 showed Effect of 851NS on white cell clasification of newborn mice
Table 2
(% X + D.SD) group mice morphonaclear p 1 value lymphocyte p 2 value*
number leukocyte (% X SD) (% X SD) control 34 58+10 42+9 851 34 42+12 < 0.001 57+12 < 0.001 * Compared with control group 2.Discussion 851 nutrient solution was a bioengineering product which contained more than 20 kinds of amino acids , several kinds of vitamines and trace elements. The results showed that 851 nutrient solution significantly increased the value of lymphocoyte of the newborn mice , which indicated that 851 NS could stimulate and improve the blood manufacturing function of the newborn mice.
The results also showed that 851NS could increase the body weight of the newborn mice , which indicated that some components of 851NS were nutritious for the newborn mice,
Experiment 6 Therapeutic effect of 851NS on the subchronic injury to gastric mucosa in mice 1. Materials
Kunming mice of both sex weighing 42-44g were supplied by the animal center of
Fu.iian Medical College. 851NS, 4N HCI and 0,1% indomethacin were used.
2. Methods 2.1 The establishment of the model of subchronic injury to gastric mucosain mice.
Eight mice were divided into 2 groups in random. Mice of the control group were administerd with normol saline once dally ,P.O. Mice of the tested group were administered with 4N HCI or 0.1% indomethacln alternately once daily, (P.
0. ) for two days. These mice were fed with normal diet and tap water. Ten days later , the mice were decapitated. The stamoch was removed and washed with water. The gastric mucosa of the control group showed lustrous and red, while the gastric mucosa of the tested group were lustreless , pale and swelling. The gastric cavity was fill with 10% neutral formalin for fixing, cut into sections with paraffin wax and stained with HE staining. Gastric mucosa were examined with microscope and showed that the endothilium of the mucosa became thiner and covered with eroded keratinic substances , gastric gland scattered with eroded necrosis. No significant changes was observed in control group. It was confirmed that the method described above could become a model of subchronic injury.
2.2 Therapeutic effect of 851NS on mice subchronic injury of gastric moucosa
Thirty mice were divided into control group and 851 group in random and administered with HCI or indomethacin alternative according to the method described above for 18 days. The mice of these two groups were fed with normal diet or the diet containing 851, respectively during 18 days and continued for 7 days after the administration of HC1 or indomethacin was stopped. Then the mice were decapitated. The change of the gastric moucosa was examined according to the method described above.
Result and Discussion
There was no significant difference of the morphology of gastric moucosa between the control and 851 groups. The mucosa in the front part of the stomach of the 851 group was a little thicker than that of the control group.
The results indicated that 851 was benificlal to the recovery of injury of gastric mucosa.
Experiment 7 Therapeutic effect of 851 on hemmorage of gastric mucosa in rats
Materials and Methods 1. Methods
Rats were divided into control and 851 groups in random and fed with normal diet and the diet containing 851 (8ml/rat ) , respectively. All rats were supplied with sufficient tap water. 15 days later, all rats were fasted for 14 hrs and administed with indomethacin (2.5mg/rat) subcutaneously once daily for two days. 18 hours aflco the second injection , rats were decapitated and the stomach was examined.
Results and Discussion 1. Results
Number and degree of acute hemorrhage of gastric mucosa : The hemorrhage of gastric mucosa in control 6 mice and 4 mice in 851 group was locally restricted as spotted , stripped or streched situation. Diffused hemorrhage of gastric mucosa occured in one rat of the control group. There were 6-12 spots hemorrhage of gastric mucosa in control group and 2-8 in 851 group. The number of hemorrhage of gastric mucosa of control group was significantly severe than that of 851 group.
2. Discussion
The results indicated that indomethasin induced hemorrhage of gastric mucosa was prevented when rats were fed with 851NS for 15 days.
Experiment 8 Effect of 851 NS on CCI. induced subchronic hepatic injury in rat
Material and Methods 1. Materials
Twenty two Wistar rats (male 10 and female 12), weighing 140-220 g were supplied by the animal center of Fujian Medical College. CCl, analytical grade, was diluted in purified peanut oil to the concentration of 48 %. 851 NS , agar gel (product of shanghai Chemical Agent Manufactory) and LEB multiple usage of electrophoresis equipment were used.
2. Methods
Twenty two rats were divided randomly into 3 groups ,i.e. control group (n=b), CCI, group (n=B) and CCl4 + 851 group (n=8). Rats of CCl4 and CCI. + 851 group were administered with CCI. (0.1ml/100g) subcutaneously twice a week (3 days interval ) , for 5 weeks. Rats of control and CC1, groups were fed with normal diet. Rats of CCI. + 851 group were fed with the diet containing 851 NS (8ml/rat.day ). All rats were supplied with sufficient tap water and fed for 5 weeks. Five days after the last administratlon of CCl4, blood was taken from the axillary vein. Serum was collected and liver function was detected.
Electrophoresis of serum protein was performed with LEB electrophoresis equipment. Pathological changes of the liver were examined.
Results and Discussion 1. Results: 1.1 Rat SGPT
Effect of 851 NS on CCl4, induced SGPT changes In rats group number SGPT(%,X + SD) p 1* p 2* control 6 29.8 + 8.0 CCI. 8 41.6 + 5.3 < 0.01 CCI. + 851 8 31.8 + 5.5 > 8,85 < 8,81 * pl compared with control group. p2 compared with CCl4 group.
1.2
There were no significant differences of thymol turbidity test (TTT) and zinc sulfate turbldity test (Zn TT) between these groups.
1.3 Observation of liver by naked eye : The color and lustre of the liver capsule in control group were normal. The liver capsule was lustrous. The rat liver capsules of CCl4 group were pale brown and lustress in accordance with the morphological changes of liver with watery degenaration. The rat liver mophology of CCI, + 851 group was better than that of CCI. group and poor than that of control group.
1.4 Observation of liver by microscope : In control group the liver histoloRical structure of 5 rats were normal except one with small watery degenaraton. Eight rats of CC I, group showed significant liver watery deReneration. Cell plasma of the outer part of liver lobule showed diffused or focal reticulated areosis , Some cells in the central part of the liver loblue were normal and some showed degeneration. Fatty deRenarated liver cells were scattered or focused and difficult to be differenciated from watery degenerated cells. Six rat liver of the CCI. + 851 group showed less watery degenaration than that of CCI. group , another 2 rats showed the same watery degenaration as that of CCI. group.Rat liver histological changes were in accordance with the results of liver function SGPT, This indicated that the results of rat SGPT in all groups were reliable.
1.5 Electrophoresis of rat serum protein : Two serum samples of each group were usesd for electrophoresis. The results showed that there were no differences among these groups. These results Indicated that CCl4 induced liver injury did still not cause changes of rat serum protein.
1.6 Increase of body weight : The increase of rat body weight of CCI, + 851 group were more than that of the other groups , but there were not statistically significant differences among these groups (p > 0.05)4 -2. Discussion
The results of rat serum SGPT and morphological changes investigated by naked eye and microscope indicated that 851 showed preventive and therapeutic effects against CCI. induced subchronic liver injury.
Experiment 9 Effect of 851 NS on the body weight development of newborn and suckling mice
Materials and Methods 1. materials
Kunming mice were supplied by the animal center of Fujian Medical College. 851
NS (batch number 86) was used.
2. Methods 27 femaleKunming mice after nating with the same species of male mice , when they were preliminary considered to be pregnant (with vaginal thrombus), were divided into control group and 851 groups randonly. Mice of control group were fed with normal diet while mice of the 851 group were fed with the diet containing 851. All mice were supplied with tap water . Seven mice were taken from each group in random and fed with the same method described above separately after they were confirmed to be pregnant from the enlarging abdomen. Newborn mice per litter were weighed at the day of parturition, and after the period of 20 days suckling. The body weight and the external appearance of the newborn mice and suckling mice were investigated.
Results and discussion 1. Results 1.1 Effect of 851NS on the body weight of the newborn mice (just after parturition)
Table 3 Effect of 851 on the body weight of newborn mice group litter number of body weight average body p*
number newborn mice of each weight of each
per litter newborn mice newborn mice
in the same in the same
litter (g.X) group (g.X50)
Control 1 13 1.54
2 10 1.70 3 9 1.70 1.61 + 0.067
4 10 1.60 5 10 1.65 6 10 1.57 7 10 1.54
7 10 1.54 851 1 12 1.66
2 11 1.77
3 8 2.15
4 9 1.85 1.83+0.15 < 0,01
5 8 1.81
6 10 1.78
7 13 1.78 * Compared with control group.
1.2 Effect of 851NS on the body weight of suckling mice were shown in table 4.
Table 4 Effect of 851NS on the body weight of suckling mice group litter number of body weight average of body p*
number suckling of the weight of the
mice suckling suckling mice
mice in the in the same
same litter group (g.X50) (g.X) control 1 10 10.60
2 9 11.30 3 11 8.45
4 8 12.60 10.521,68
5 8 11.2e 6 13 8.00
7 8 11.50 851 1 9 13.00
2 9 12.85
3 9 11.53
4 8 14.75 12.44 1.81 < 0,05
5 8 14.36
6 10 10,64
7 13 9.98 * Compared with control group.
1.3 No abnormal phenomenon of external appearance , capacity for eating and general activities were observed.
2. Discussion 2.1 Table 3 showed that 851NS could promote the body weight development of the mouse embryo when the female mice were fed with 851 NS during the period of pregnancy (p < 8.81).
2.2 Table 4 showed that 851 NS could promote the body weight development of the suckling mice when the female mice were fed with 851 NS during the period of the suckling (p C 8.85).
2.3 The results indicated that no abnormal development (such as fetus malformation ) and adverse effect were observed when female mice were fed with 851 NS during 40 days period from pregnancy to suckling.
The embodiments of the present invention are described , but not limited , in detail as follows:
Example 1
A 2.5 ton tank fermenter was used in this production. The seed fermenter was of 0.5 ton. The amount of raw materials taken in was 40 %, a 5 % soybean medium was adopted as the producing medium containing : 5 % of soybean powder , 0.04 % of yeast extract , 8.85 % KH2PO., 0,02 % of MgSO4, 0.02 % of CaCO3 , 0.02 % of NaCI , 10 ppm of Na2MoO4 , 2.5ppm of Na2SeO3, 10 ppm of
ZnSO, , 2.5 ppm of CoCl2 and water.The amount of Inoculum was 1 % , the seed fermenter was of 2 liters, the cell age was 24 hrs, (the first seed culture - the second sed culture -- the third seed culture , the culture incubated for 24 hrs was used as Inoculum. ) culture temperature was 30t.
stirring speed was 260rpm , the aeration rate was 1 :8 ,8 vvm. The culture incubation lasted for 45 hrs. After terminating the incubation , the culture was autoclaved and packed into bottles through an assembly line , then autoclaved again to give final products. 100ml of the culture solution contained : 3.7 % of dry material, 2,06 % of proteins, 0,23 % of lipids, 0,75 % carbohydrates, vitamins and mineral salts.(llsted In Table 5)
Table 5 Analytical report of 851 culture solution
Constituents Unit Amount Constituents Unit Amount eatable part g 100 asparic acid mg 87.8 water g 96.3 glutamic acid mg 93.8 protein g 2,06 serine mg 28.1 lipid g 0.23 proline mg 29.0 carbohydrate g 0.75 glycine mg 33.6 heat of capacity kcal 13.3 alanine mg 48.1 eatable threonine mg 30.0 cellulose g 0.26 valine mg 37.0 ash g 0,40 methionine mg 10,9 ------------------------------ isoleucine mg 26. 1 K mg 49.0 leucine mg 51.4
Na mg 18.0 tyrosine mg 22.0
Ca mg 39.5 phenylalanine mg 24.0
Fe mg 2.3 lysine mg 34.7
Zn mg 4.4 tryptophen mg 10.0
Cu mg 0.05 histidine mg 14.2
Mn mg 0.14 arginine mg 39.6
Mg mg 5.3 -----------------
P mg 42.9 myristic acid %
Se ng 0,05 palmitic acid % 14.4 ------------------------------- stearic acid % 85.5 vitamin E mg 0,64 vitamin B2 mg 0.13 vitamin PP mg 0.47
Example 2
An 8 ton tank fermenter was used in this production. The amount taken in of raw materials was 40 %. It means that the amount of medium was 3.2 ton. A 10 % soybean milk medium was adopted.The medium contained: 320 kg of soybeans,1.28 kg of yeast extract , 1.6 kg of KH2PO,. 648g of MgSO4 , 640g of CaCO3, 640g of NaCI , 32g of Na2MoO4, 8g of Na2SeO3, 32g of ZnSO4, 8g of CoCl2 and water.
The amount of inoculum was 1 % , the cell age was 24 hrs , (the first seed culture, the second seed culture and the third seed culture , the culture incubated for 24 hrs was used as inoculum. -) The culture temperature : 30 C, the stirring speed : 220rpm. the aeration rate : 1:0,8 vvm. After finishing the incubation in a seed fermenter , the inoculum was inoculated into an 8 ton tank fermenter , the culture temperature : 30 C, the stirring speed : 220 rpm , the aeration rate : 1 :0.8 vvm.The incubation was terminated after 48 hrs and the culture solution was autoclaved and packed into bottles through an assembly line, then autoclaved again to give the final products. 100 ml of the culture solution contained : aspartic acid 543mg , glutamic acid 710mg, serine 160mg , glycine 280mg, histidine 65mg, argining 226mg, threonine 232mg, alanine 359mg , proline 126mg , tyrosine 101mg, valine 283mg, methionine 53mg, isoleucine 262mg , leucine 309mg , phenylalanine 148mg , lysine 212mg, cystine 38mg, the total amount : 4127mg.
Examle 3
The nutrient solution produced by the method given in example 2 was dried by a spray dryer usually used to make dried milk to give 851 nutrient powder.
The temperature was of 80C at the spray dryer entrance and 60 C at the exit. 0.8 ton of 851 nutrient solution gave 20.4 kg of dried powder , which was further processed into capsules. One capsule contained 0.28g of dried powder or formulated with 80kg of starch and 10 kg of honey to make granule preparations.
Example 4
The 851 nutrient solution produced by conventional fermentation method was centrlfuged to get rid of precipitate , at 15000 rpm. Thus 1 ton of 851 nutrient solution gave 960 kg of supernatant. 851 fruit juice cola was prepared by adding 500 kg of fruit juice , 851 honey cola was prepared by adding 40 kg of honey. The supernatant mentioned above might also be flavoured to give a variety of 851 drinks with different taste according to needs.
Example 5
The 851 nutrient solution produced by conventional fermentation method was centrifuged. The supernatant was concentrated by a film evaporator or a vaccum rotatory evaporator to give 851 concentrated nutrients. After evaPoration 0,5 ton of the supernatant gave 100kg of concentrated nutrient. After adding 10 kg of honey , the concentrated nutrient was packed into small bottles with easy-to-open cap. This nutrient is convenient to be taken orally.
Claims (10)
1. A microbacterium strain 851R having the capability to convert plant protein to single cell protein and possessing the following characteristics: a Gram-positive bacterium, motionless, able to produce H2S, nitrate reduction positive, alive in milk being heated to 60 for 30 minutes or to 72"C for 15 minutes, the thallus being of red or orange red colour, the colour of the thallus being turned to pink at 38"C and to colourless at 40"C, the DNA of the strain containing R fragment.
2. The strain 851R according to claim 1, in which the R fragment in the DNA of the strain can be detected by a special R fragment DNA probe.
3. The strain 851R according to claim 1 or 2, in which the plant protein is soybean protein.
4. A microbacterium 851R having the essential characteristics of the sample on deposit with American Type Culture Collection 12301 Parklawn Drive, Rockville, Maryland 20852 USA, and assigned
A.T.C.C. No. 53981.
5. A method for producing single cell protein nutrient solution by using bacterium, in which the microbacterium strain 851R, is used as a producing strain and a soybean powder medium or starch medium is adopted as the producing medium to produce 851R nutrient solution be fermentation.
6. A method according to claim 5, in which over dry spray processing to harvest single cell protein from the culture solution and concentration processing to refine the culture solution are used.
7. A medium for the strain 851R according to any of claims 1 to 4, containing the following components by weight:
Soybean powder or soybean milk 5 - 10% (Calculated as the weight of soybean) 5 - 20% or various bean cakes sunflower seed cake 5 - 10%
Yeast extract or yeast powder 0.02 - 0.5% CaCO2 0.05 - 0.5% K2HPO4 0.02 - 0.2% MgSO4 0.01 - 0.08%
NaCl 0.01 - 0.08% Na2MoO4 5 - 50 ppm
Na2SeO3 1.5 - 10 ppm ZnSO4 2.5 - 50 ppm
CoCl2 2.5 - 50 ppm
8. A medium for the strain 851R according to any of claims 1 to 4, containing the following components (percentage by weight):
Fresh materials containing srarch 10 - 20% (Sweet potato, potato, etc.) or dry materials containing starch 1 - 10% (corn powder, etc.)
Yeast extract 0.04 - 0.08% CaCO3 0.05 - 0.5%
K2HPO4 0.05 - 0.1% MgSO4 0.02 - 0.04%
NaCl 0.02 - 0.04% Na2MoO4 10 - 20 ppm
Na2SeO3 1.5 - 20 ppm
ZnSO4 5 - 20 ppm
CoCl2 5 - 20 ppm
9. A nutrient solution produced by fermentation with the strain microbacterium 851R in a medium containing nitrogen source.
10. Products made of bacteria of the strain 851R or of 851 nutrient solution.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN89104615A CN1023409C (en) | 1989-07-11 | 1989-07-11 | Nutritive liquid |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9010885D0 GB9010885D0 (en) | 1990-07-04 |
GB2233666A true GB2233666A (en) | 1991-01-16 |
GB2233666B GB2233666B (en) | 1993-08-04 |
Family
ID=4855628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9010885A Expired - Fee Related GB2233666B (en) | 1989-07-11 | 1990-05-15 | Microbacterium strain 851, culture media for same and production of single cell nutrient solution. |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2613664B2 (en) |
CN (1) | CN1023409C (en) |
AU (1) | AU624690B2 (en) |
CA (1) | CA2012278C (en) |
GB (1) | GB2233666B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992021749A1 (en) * | 1991-06-03 | 1992-12-10 | Innovi N.V. | Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1101471C (en) * | 2000-05-26 | 2003-02-12 | 黑龙江省轻工科学研究院 | Process for preparing active peptide of soybean protein |
US7472891B2 (en) | 2006-01-30 | 2009-01-06 | Michael D. Schram | Bollard assembly |
CN102719369B (en) * | 2011-06-14 | 2013-12-04 | 广西中烟工业有限责任公司 | Microbial strain and application thereof |
JP6138048B2 (en) * | 2011-10-12 | 2017-06-07 | フォーデイズ株式会社 | Cysteine peptide-containing health drink |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4920052A (en) * | 1988-02-05 | 1990-04-24 | Miles Inc. | Process for producing glucose isomerase |
-
1989
- 1989-07-11 CN CN89104615A patent/CN1023409C/en not_active Expired - Fee Related
-
1990
- 1990-03-15 CA CA002012278A patent/CA2012278C/en not_active Expired - Fee Related
- 1990-03-22 AU AU52100/90A patent/AU624690B2/en not_active Ceased
- 1990-05-15 GB GB9010885A patent/GB2233666B/en not_active Expired - Fee Related
- 1990-07-11 JP JP2183854A patent/JP2613664B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
Bergey`s Manual of Determinative Bacteriology (Eighth Edition), pages 628-629 … * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992021749A1 (en) * | 1991-06-03 | 1992-12-10 | Innovi N.V. | Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof |
US6479050B1 (en) | 1991-06-03 | 2002-11-12 | Innovi N.V. | Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof |
Also Published As
Publication number | Publication date |
---|---|
JPH0349680A (en) | 1991-03-04 |
CA2012278A1 (en) | 1991-01-11 |
GB9010885D0 (en) | 1990-07-04 |
JP2613664B2 (en) | 1997-05-28 |
CA2012278C (en) | 1998-06-02 |
CN1042376A (en) | 1990-05-23 |
CN1023409C (en) | 1994-01-05 |
AU624690B2 (en) | 1992-06-18 |
AU5210090A (en) | 1991-01-17 |
GB2233666B (en) | 1993-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1308183A3 (en) | Method of producing extracts,possessing antiulcerous,insulin-like,antilipidic activity promoting nutrition assimilation,from animal carcasses | |
CN102271535B (en) | Sialic acid producing bacteria | |
JPH08214893A (en) | Method for forming arachidonic acid | |
AU2019204868A1 (en) | Production method of high bioactivity whole egg fermentation, and products and applications thereof | |
FR2516355A1 (en) | MATERNIZED MILK AND METHODS OF MANUFACTURING SUCH MILK | |
KR20120031522A (en) | Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract | |
JP2007029090A (en) | Method for producing low-degeneration defatted rice bran | |
US6677143B2 (en) | Method for culturing Bacillus subtilis natto to produce water-soluble vitamin K and food product, beverage, or feed containing the cultured microorganism or the vitamin K derivative | |
US6203835B1 (en) | Use of hydroxy acid or a product containing the same in animal feed | |
CA2012278C (en) | Mutant of microbacterium, a strain 851r, and a process for producing 851r nutrient solution by application of the strain | |
JPS60196157A (en) | Food containing euglena | |
US4085229A (en) | Process for the treatment of cakes and seeds of vegetable origin | |
CN1246144A (en) | Clostridium butyricum having preventive and therapeutic effects on hepatopathy, and liver supporting agents, foods and feeds each containing culture medium thereof | |
JP2001136959A (en) | Culture product containing bacillus subtilis cell and/or product thereof, water-soluble vitamin k derivative originated from the same, medicine, food and feed containing the same and method for producing the same | |
KR20080078460A (en) | Novel lactrobacillus buchneri and use thereof | |
CA2020633C (en) | Mutant of pseudomonas, a strain yzh, and a process for producing 851 yzh nutrient solution by application of the strain | |
CN1602708A (en) | Active bifidobacteria contained milk powder and its preparation method | |
CN100419071C (en) | Bacillus of high proteinase yield and its induction mutation breeding method and uses | |
KR102508306B1 (en) | Method for Producing Egg Having Improved Lutein and Zeaxanthin Content, Egg Produced By Same, and Method for Preparing Egg Yolk Oil or Egg Yolk Powder | |
JP2001000175A (en) | Culture of bacillus subtilis, cultured product of microorganism thereby, water-soluble vitamin k derivative derived from the same cultured product, and food, drink and feed which comprise cultured product of microorganism of vitamin k derivative | |
CN106795541B (en) | Culture containing menadione-7 and method for producing menadione-7 | |
JP2005323596A (en) | Method for producing vitamin k by culture of unnan sl-001 strain | |
Beresto | Our experience in spirulina feeding to minks in the reproduction period | |
SU1081843A1 (en) | Method of producing protein hydrolysate from sunflower grist | |
CN1042821A (en) | The production method of paddy plumule nutritious drink goods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20000515 |